These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2732345)

  • 1. Hyaluronidase production in Streptococcus milleri in relation to infection.
    Unsworth PF
    J Clin Pathol; 1989 May; 42(5):506-10. PubMed ID: 2732345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cultural and biochemical characters of Streptococcus milleri strains isolated from human sources.
    Ball LC; Parker MT
    J Hyg (Lond); 1979 Feb; 82(1):63-78. PubMed ID: 762404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological and biological characteristics of "Streptococcus milleri" isolates from systemic purulent infections.
    Kitada K; Nagata K; Yakushiji T; Eifuku H; Inoue M
    J Med Microbiol; 1992 Mar; 36(3):143-8. PubMed ID: 1548688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococci and aerococci associated with systemic infection in man.
    Parker MT; Ball LC
    J Med Microbiol; 1976 Aug; 9(3):275-302. PubMed ID: 785000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of Streptococcus milleri from clinical specimens.
    Kambal AM
    J Infect; 1987 May; 14(3):217-23. PubMed ID: 3585033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic differentiation and biochemical and serological characteristics of the clinical isolates of Streptococcus angiosus, S. intermedius and S. constellatus.
    Taketoshi M; Kitada K; Yakushiji T; Inoue M
    Microbios; 1993; 76(307):115-29. PubMed ID: 8295553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lancefield grouping and smell of caramel for presumptive identification and assessment of pathogenicity in the Streptococcus milleri group.
    Brogan O; Malone J; Fox C; Whyte AS
    J Clin Pathol; 1997 Apr; 50(4):332-5. PubMed ID: 9215152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronidase production by groups A, B, C, and G streptococci: a statistical analysis.
    Benchetrit LC; Avelino CC; Barrucand L; Sá Figueiredo AM; de Oliveira CM
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):27-37. PubMed ID: 6380153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodominant antigens of Streptococcus equisimilis shared by other beta-haemolytic streptococci.
    Cimolai N; Mah DG
    J Med Microbiol; 1994 May; 40(5):323-9. PubMed ID: 8176719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and characterization of beta-hemolytic Streptococcus milleri and differentiation from S. pyogenes (group A), S. equisimilis (group C), and large-colony group G streptococci.
    Lawrence J; Yajko DM; Hadley WK
    J Clin Microbiol; 1985 Nov; 22(5):772-7. PubMed ID: 3902878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and bacteriological significance of the Streptococcus milleri group in deep neck abscesses].
    Fujiyoshi T; Okasaka T; Yoshida M; Makishima K
    Nihon Jibiinkoka Gakkai Kaiho; 2001 Feb; 104(2):147-56. PubMed ID: 11257779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of rapid carbohydrate utilisation test for identifying "Streptococcus milleri group".
    Whitworth JM; Ross PW; Poxton IR
    J Clin Pathol; 1991 Apr; 44(4):329-33. PubMed ID: 2030154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restricted distribution of Streptococcus milleri carbohydrate type antigens amongst other viridans streptococci.
    Inoue M; Matsunoshita N; Yakushiji T
    J Med Microbiol; 1992 Sep; 37(3):211-3. PubMed ID: 1518038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and physiological characterization of Streptococcus milleri strains from human dental plaque.
    Yakushiji T; Katsuki M; Yoshimitsu A; Mizuno J; Inoue M
    Microbios; 1988; 55(224-225):161-71. PubMed ID: 3063926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyalurodinase activity of beta-hemolytic streptococci of the Lancefield group C].
    Balke E; Weiss R; Seipp A
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):194-200. PubMed ID: 4013559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of Streptococcus viridans in clinical specimens].
    Roncoroni AJ; Bianchi L; García Damiano C; Fernandez H; Bianchini HM
    Rev Argent Microbiol; 1987; 19(1):19-26. PubMed ID: 3685392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group C streptococci in human infection: a study of 308 isolates with clinical correlations.
    Barnham M; Kerby J; Chandler RS; Millar MR
    Epidemiol Infect; 1989 Jun; 102(3):379-90. PubMed ID: 2737252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential pathogenic properties of members of the "Streptococcus milleri" group in relation to the production of endocarditis and abscesses.
    Willcox MD
    J Med Microbiol; 1995 Dec; 43(6):405-10. PubMed ID: 7473673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microbiology of streptococcal infections].
    Peuckert W
    Klin Padiatr; 1985; 197(1):5-8. PubMed ID: 3974168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Streptococcus milleri" endocarditis caused by Streptococcus anginosus.
    Woo PC; Tse H; Chan KM; Lau SK; Fung AM; Yip KT; Tam DM; Ng KH; Que TL; Yuen KY
    Diagn Microbiol Infect Dis; 2004 Feb; 48(2):81-8. PubMed ID: 14972375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.